Zeo ScientifiX (ZEOX) Operating Income (2012 - 2026)
Zeo ScientifiX (ZEOX) posted quarterly Operating Income of -$512000.0 for Q2 2026, up 63.27% year-over-year from -$313588.8 in Q2 2025, and up 41.69% quarter-over-quarter from -$878000.0 in Q1 2026.
Zeo ScientifiX (ZEOX) Operating Income (2012 - 2026) Analysis & Trends
Zeo ScientifiX's Operating Income history runs 15 years deep, the most recent figure standing at -$512000.0 for Q2 2026.
- In Q2 2026, Operating Income rose 63.27% year-over-year to -$512000.0; the TTM figure through Apr 2026 stood at -$4.1 million (up 21.2% YoY), while the FY2025 annual figure was -$5.4 million, down 1.26% from the prior year.
- Operating Income for Q2 2026 stood at -$512000.0, up from -$878000.0 in the prior quarter.
- The five-year high for Operating Income was -$512000.0 in Q2 2026, with the low at -$3.2 million in Q4 2022.
- The 5-year median for Operating Income is -$1.4 million (2024), against an average of -$1.5 million.
- Peak annual rise in Operating Income reached 79.9% in 2022, while the deepest fall reached 233.99% in 2022.
- Zeo ScientifiX's Operating Income stood at -$3.2 million in 2022, then surged by 61.27% to -$1.2 million in 2023, then dropped by 15.67% to -$1.4 million in 2024, then soared by 53.12% to -$668000.0 in 2025, then advanced by 23.35% to -$512000.0 in 2026.
- Business Quant data shows ZEOX's Operating Income at -$512000.0 in Q2 2026, -$878000.0 in Q1 2026, and -$668000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.29 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 493.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -815.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 325.05 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 231.44 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -375.75 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -1.55 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 133.12 Mn |
| 10 | Zeo ScientifiX | 10.51 Mn | 8.67 Mn | 2.06 Mn | -512,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -512,000.00 |
| Jan 31, 2026 | -878,000.00 |
| Oct 31, 2025 | -668,000.00 |
| Jul 31, 2025 | -2.07 Mn |
| Apr 30, 2025 | -1.39 Mn |
| Jan 31, 2025 | -1.25 Mn |
| Oct 31, 2024 | -1.43 Mn |
| Jul 31, 2024 | -1.17 Mn |
| Apr 30, 2024 | -1.56 Mn |
| Jan 31, 2024 | -1.16 Mn |
| Oct 31, 2023 | -1.23 Mn |
| Jul 31, 2023 | -1.45 Mn |
| Apr 30, 2023 | -1.91 Mn |
| Jan 31, 2023 | -2.18 Mn |
| Oct 31, 2022 | -3.18 Mn |
| Jul 31, 2022 | -2.76 Mn |
| Apr 30, 2022 | -1.26 Mn |
| Jan 31, 2022 | -1.64 Mn |
| Oct 31, 2021 | -952,382.00 |
| Jul 31, 2021 | -1.39 Mn |